The United Laboratories International Holdings Limited (ULIHF)

Market Cap	1.91B -51.0%
Revenue (ttm)	1.75B -15.9%
Net Income	79.38M -82.4%
EPS	0.04 -83.7%
Shares Out	n/a
PE Ratio	24.11
Forward PE	12.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,500
Open	1.010
Previous Close	1.015
Day's Range	1.010 - 1.015
52-Week Range	1.010 - 1.875
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 31, 2026

About ULIHF

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers amoxicillin products; insulin series, antibiotics, and ophthalmic products; and veterinary drugs. It also provides 6-aminopenicillanic acid and penicillin G potassium products. In addition, the company provides endocrine and metabolism, anti-...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1990
• Employees: 18,000
• Stock Exchange: OTCMKTS
• Ticker Symbol: ULIHF

Financial Performance

In 2025, ULIHF's revenue was 13.21 billion, a decrease of -3.99% compared to the previous year's 13.76 billion. Earnings were 2.09 billion, a decrease of -21.57%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 25, 2026

Data Sources Report a data error